"Despite the benefits of cervical cancer screening, not all women and people with a cervix get screened regularly," Dr. William Dahut, chief scientific officer at the American Cancer Society, said in a press release when the FDA approved the test. This highlights a crucial gap in regular screenings, underscoring the need for more accessible methods to encourage participation in cervical cancer prevention.
"The new self-administered test could significantly improve this crucial checkup's accessibility and tolerability," as the process will permit patients to collect their own samples. This shift is expected to potentially increase screening rates by reducing discomfort associated with traditional Pap smears.
Collection
[
|
...
]